A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
Schmitz-Winnenthal, Friedrich H., Hohmann, Nicolas, Schmidt, Thomas, Podola, Lilli, Friedrich, Tobias, Lubenau, Heinz, Springer, Marco, Wieckowski, Sébastien, Breiner, Klaus M., Mikus, Gerd, Büchler, Markus W., Keller, Anne-Valerie, Koc, Ruhan, Springfeld, Christoph, Knebel, Phillip, Bucur, Mariana, Grenacher, Lars, Haefeli, Walter E., Beckhove, Philipp
Published in Oncoimmunology (03.04.2018)
Published in Oncoimmunology (03.04.2018)
Get full text
Journal Article
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer
Niethammer, Andreas G, Lubenau, Heinz, Mikus, Gerd, Knebel, Philipp, Hohmann, Nicolas, Leowardi, Christine, Beckhove, Philipp, Akhisaroglu, Mustafa, Ge, Yingzi, Springer, Marco, Grenacher, Lars, Buchler, Markus W, Koch, Moritz, Weitz, Jürgen, Haefeli, Walter E, Schmitz-Winnenthal, Friedrich H
Published in BMC cancer (20.08.2012)
Published in BMC cancer (20.08.2012)
Get full text
Journal Article
Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphoma
Engert, Andreas, del Giglio, Auro, Bias, Peter, Lubenau, Heinz, Gatzemeier, Ulrich, Heigener, David
Published in Onkologie (01.10.2009)
Published in Onkologie (01.10.2009)
Get more information
Journal Article
Oral DNA vaccination targeting VEGFR2 combined with anti-PDL1 avelumab in patients with progressive glioblastoma: Safety run-in results—NCT03750071
Wick, Wolfgang, Wick, Antje, Chinot, Olivier L., Van Den Bent, Martin J., De Vos, Filip Yves Francine Leon, Mansour, Marc, Podola, Lilli, Lubenau, Heinz, Platten, Michael
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Oral DNA vaccination targeting VEGFR-2 combined with anti-PD-L1 avelumab in patients with progressive glioblastoma, a phase I/II study: NCT03750071
Wick, Wolfgang, Wick, Antje, Platten, Michael, Chinot, Olivier L., Van Den Bent, Martin J., Dhermain, Frederic, Mansour, Marc, Podola, Lilli, Lubenau, Heinz
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
Gatzemeier, Ulrich, Ciuleanu, Tudor, Dediu, Mircea, Ganea-Motan, Elena, Lubenau, Heinz, Del Giglio, Auro
Published in Journal of thoracic oncology (01.06.2009)
Published in Journal of thoracic oncology (01.06.2009)
Get full text
Journal Article
Abstract 733: Modulating T cell immunity in tumors by targeting PD-L1 and neoantigens using a live attenuated oral Salmonella platform
Wieckowski, Sébastien, Podola, Lilli, Smetak, Heiko, Nugues, Anne-Lucie, Slos, Philippe, Berkane, Amine Adda, Wei, Ming, Breiner, Klaus, Meichle, Albrecht, Beckhove, Philipp, Mansour, Marc, Lubenau, Heinz
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4558: Immunogenicity and antitumor efficacy of live attenuated Salmonella typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m
Wieckowski, Sébastien, Podola, Lilli, Springer, Marco, Kobl, Iris, Koob, Zina, Mignard, Caroline, Berkane, Amine Adda, Wei, Ming, Meichle, Albrecht, Breiner, Klaus, Schroff, Matthias, Beckhove, Philipp, Lubenau, Heinz
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article